Valid novel pyrrolodihydroisoquinoline in the treatment of cancer
2004
The present invention relates to novel pyrrolodihydroisoquinoline derivatives, which are cells (excess) inducers of apoptosis in effective inhibitor and / or cancer cell growth.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI